Production (Stage)
BioScience Health Innovations, Inc.
BHIC
$9.01
-$0.99-9.90%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 101.10% | 6.49% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 101.10% | 6.49% | |||
| Cost of Revenue | 22.01% | 83.00% | |||
| Gross Profit | 164.34% | -20.18% | |||
| SG&A Expenses | 42.60% | -10.69% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.32% | 16.16% | |||
| Operating Income | 4,168.00% | -82.21% | |||
| Income Before Tax | 4,168.00% | -82.21% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4,168.00% | -82.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4,168.00% | -82.21% | |||
| EBIT | 4,168.00% | -82.21% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 4,750.00% | -84.62% | |||
| Normalized Basic EPS | 6,000.00% | -87.50% | |||
| EPS Diluted | 4,750.00% | -84.62% | |||
| Normalized Diluted EPS | 5,900.00% | -87.50% | |||
| Average Basic Shares Outstanding | 2.96% | 1.33% | |||
| Average Diluted Shares Outstanding | 0.01% | 5.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||